Apalutamide (APA) for metastatic castration-sensitive prostate cancer (mCSPC) in TITAN: Outcomes in patients (pts) with low- and high-risk disease


Ozguroglu M. , Chowdhury S., Bjartell A., Uemura H., Chung B. H. , Agarwal N., ...Daha Fazla

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Kostarika, 13 - 15 Şubat 2020, cilt.38 identifier

  • Cilt numarası: 38
  • Basıldığı Şehir: San-Francisco
  • Basıldığı Ülke: Kostarika